Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO My JCO Subscriptions Customer Service Site Map

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Right arrowRights & Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Esnaola, N. F.
Right arrow Articles by Skibber, J. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Esnaola, N. F.
Right arrow Articles by Skibber, J. M.
Journal of Clinical Oncology, Vol 20, Issue 21 (November), 2002: 4361-4367
© 2002 American Society for Clinical Oncology

Pain and Quality of Life After Treatment in Patients With Locally Recurrent Rectal Cancer

By Nestor F. Esnaola, Scott B. Cantor, Margo L. Johnson, Attiqa N. Mirza, Alexander R. Miller, Steven A. Curley, Christopher H. Crane, Charles S. Cleeland, Nora A. Janjan, John M. Skibber

From the Departments of Surgery, Biostatistics, and Radiation, and Pain Research Group, The University of Texas M.D. Anderson Cancer Center, Houston, and Department of Surgery, The University of Texas Health Science Center, San Antonio, TX.

Address reprint requests to Nestor F. Esnaola, MD, MPH, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 444, Houston, TX 77030-4009; email: nesnaola{at}mdanderson.org

PURPOSE: Because survival in patients with locally recurrent rectal cancer (LRRC) is limited, pain control and quality of life (QOL) are important parameters. The purpose of this study was to assess the prevalence of posttreatment pain and QOL of patients with LRRC treated with nonsurgical palliation or resection and identify predictors of poor outcome.

PATIENTS AND METHODS: Posttreatment pain severity and QOL were prospectively assessed in 45 patients with LRRC using the Brief Pain Inventory and Functional Assessment of Cancer Therapy–Colorectal questionnaire.

RESULTS: Fifteen patients received nonsurgical palliation, and 30 patients underwent resection of their pelvic tumors. There was a significant association between higher posttreatment pain scores and worse QOL (P < .001). Patients treated with nonsurgical palliation reported moderate to severe pain beyond the third month of treatment. Resected patients reported comparable levels of pain during the first 3 postoperative years, particularly after bony resections; long-term survivors (beyond 3 years), however, reported minimal pain and good QOL. Female sex, pelvic/sciatic pain at presentation, total pelvic exenteration, and bony resection were associated with higher rates of moderate to severe posttreatment pain (P = .04, P < .001, P = .04, and P = .02, respectively). Pain at presentation was an independent predictor of posttreatment pain (odds ratio, 7.4 [95% confidence interval, 1.8 to 30.3]; P = .006).

CONCLUSION: Patients with LRRC treated with nonsurgical palliation or resection experience significant levels of pain after treatment. Close posttreatment pain monitoring is warranted in patients presenting with pelvic pain, and more aggressive pain management strategies may improve posttreatment QOL.




This article has been cited by other articles:


Home page
Ann OncolHome page
M. van den Beuken-van Everdingen, J. de Rijke, A. Kessels, H. Schouten, M van Kleef, and J Patijn
Prevalence of pain in patients with cancer: a systematic review of the past 40 years
Ann. Onc., September 1, 2007; 18(9): 1437 - 1449.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
L. R. Henry, E. Sigurdson, E. A. Ross, J. S. Lee, J. C. Watson, J. D. Cheng, G. M. Freedman, A. Konski, and J. P. Hoffman
Resection of Isolated Pelvic Recurrences after Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome
Ann. Surg. Oncol., July 1, 2007; 14(7): 2000 - 2009.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
C. J. Gannon, J. S. Zager, G. J. Chang, B. W. Feig, C. G. Wood, J. M. Skibber, and M. A. Rodriguez-Bigas
Pelvic Exenteration Affords Safe and Durable Treatment for Locally Advanced Rectal Carcinoma
Ann. Surg. Oncol., June 1, 2007; 14(6): 1870 - 1877.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
L. R. Henry, E. Sigurdson, E. A. Ross, J. S. Lee, J. C. Watson, J. D. Cheng, G. M. Freedman, A. Konski, and J. P. Hoffman
Resection of Isolated Pelvic Recurrences After Colorectal Surgery: Long-Term Results and Predictors of Improved Clinical Outcome
Ann. Surg. Oncol., March 1, 2007; 14(3): 1081 - 1091.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
B. J. Wells, P. Stotland, M. A. Ko, W. Al-Sukhni, J. Wunder, P. Ferguson, J. Lipa, L. Last, A. J. Smith, and C. J. Swallow
Results of an Aggressive Approach to Resection of Locally Recurrent Rectal Cancer
Ann. Surg. Oncol., February 1, 2007; 14(2): 390 - 395.
[Abstract] [Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
T. M. Pawlik, J. M. Skibber, and M. A. Rodriguez-Bigas
Pelvic Exenteration for Advanced Pelvic Malignancies
Ann. Surg. Oncol., May 1, 2006; 13(5): 612 - 623.
[Full Text] [PDF]


Home page
Ann. Surg. Oncol.Home page
L. Stocchi, H. Nelson, D. J. Sargent, D. E. Engen, and M. G. Haddock
Is En-Bloc Resection of Locally Recurrent Rectal Carcinoma Involving the Urinary Tract Indicated?
Ann. Surg. Oncol., May 1, 2006; 13(5): 740 - 744.
[Abstract] [Full Text] [PDF]


Home page
The OncologistHome page
A. Trentham-Dietz, P.L. Remington, C.M. Moinpour, J.M. Hampton, A.L. Sapp, and P.A. Newcomb
Health-Related Quality of Life in Female Long-Term Colorectal Cancer Survivors
Oncologist, August 1, 2003; 8(4): 342 - 349.
[Abstract] [Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 PDA Services

Copyright © 2002 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online